The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom

Documenti analoghi

• Empowering citizens to spontaneously report suspected adverse drug reaction: Systematic literature review of interventions and their impact
  di: Margarida Perdigão, et al.
  Pubblicazione: (2026)
• Evaluating a virtual paediatric adverse drug reaction clinic
  di: Emily Hauck, et al.
  Pubblicazione: (2026)
• The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions—A backward selection approach
  di: Judith Berres, et al.
  Pubblicazione: (2026)
• EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding
  di: Ida M. Heerfordt, et al.
  Pubblicazione: (2025)
• Investigation of absorption, metabolism, and excretion of [ 14 C]pruxelutamide (GT0918), an androgen receptor antagonist in humans
  di: Yuan‐dong Zheng, et al.
  Pubblicazione: (2025)